Plummer, Chris
Driessen, Christoph
Szabo, Zsolt
Mateos, MarĂa-Victoria
Funding for this research was provided by:
Amgen (Europe) GmbH
Article History
Received: 21 June 2018
Revised: 16 November 2018
Accepted: 30 January 2019
First Online: 26 February 2019
Conflict of interest
: CJ Plummer has received honoraria for advisory boards and speaker meetings from Amgen, Pfizer, and Roche. C Driessen is an advisor to Amgen and Janssen. Z Szabo is an employee of Amgen and holds stock. M-V Mateos has received honoraria and participated in advisory boards from Janssen, Celgene, Amgen, Novartis, BMS, and Takeda.